Initiatives to Increase Communication Between the USPTO and the FDA Concerning Pharmaceutical Patent Applications | Dechert LLP
President Biden, in July 2021, issued an Executive Order (“E.O.”) observing that “too often, patent and other laws have been misused to inhibit or delay — for years and even decades —...
Source: jdsupra.com